$18.93
-0.30-1.56%
Last update: Nov 20, 2:38 PM

The average analyst price target for Replimune Group is $16.44, 13.2% below the current price. Of 9 analysts, 6 rate it Buy, 2 Hold and 1 Sell. Targets range from $2 to $31. The latest change came on Nov 16, 2026, when Piper Sandler raised its price target on Replimune Group from $14 to $27 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months